Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smartblood is a UK private healthcare testing company that offers direct-to-consumer, home-to-lab food intolerance tests based on finger-prick blood sampling and IgG reactivity analysis. The company markets its service as a way to help consumers identify foods and drinks that may be associated with symptoms such as bloating, fatigue, headaches, skin issues, and joint discomfort. Its core offering is a commercially available test kit, supported by online educational content and access to nutrition-related guidance rather than a therapeutic drug pipeline. Based on the available evidence, Smartblood is a health-related diagnostics and wellness testing business rather than a biotech or pharmaceutical drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smartblood.